Deutsche Bank's Top Q3 Healthcare Stocks: PFE, MRK, JNJ, GILDWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection an…
Onyx Pharmaceuticals Presents Carfilzomib Data at 53rd American Society of … – MarketWatch (press release)
Onyx Pharmaceuticals Presents Carfilzomib Data at 53rd American Society of …MarketWatch (press release)Prior therapies included alkylating agents, stem cell transplant, thalidomide, lenalidomide and anthracyclines, and bortezomib in the bortezomib-tr…
Obinutuzumab: New Drug to Replace Rituximab? – Medscape
Obinutuzumab: New Drug to Replace Rituximab?MedscapeDecember 12, 2011 (San Diego, California) — For more than a decade now, rituximab (Rituxan, Genentech) has reigned supreme as the only drug of its kind — a monoclonal antibody specifically targeti…
Celgene and Covidien Lead Legg Mason's $332M Healthcare Stock Portfolio – Wall St. Cheat Sheet
Celgene and Covidien Lead Legg Mason's $332M Healthcare Stock PortfolioWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant re…
Access Hollywood – Celebrity News, Photos & Videos – Access Hollywood
Access HollywoodAccess Hollywood – Celebrity News, Photos & VideosAccess HollywoodAfter this I go in for another stem cell transplant and after that I'll be healed and cured for life.” In September, Ethan's rare form of Hodgkin's dise…
Researchers say therapy improves stem cell engraftment in umbilical cord blood … – EurekAlert (press release)
Science CodexResearchers say therapy improves stem cell engraftment in umbilical cord blood …EurekAlert (press release)SAN DIEGO—A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in pa…
ASH 2011 Multiple Myeloma Update – Day Two – The Myeloma Beacon
ASH 2011 Multiple Myeloma Update – Day TwoThe Myeloma BeaconNearly 70 percent of the participants successfully collected enough stem cells and underwent a stem cell transplant in addition to the T-BiRD regimen. However, 31 percent of the trial partic…
Benefit of Romiplostim vs. Standard of Care (SOC) and SOC+Rituximab in … – Monthly Prescribing Reference
Benefit of Romiplostim vs. Standard of Care (SOC) and SOC+Rituximab in …Monthly Prescribing ReferenceEleven of 16 patients in the SOC arm received rituximab 219–363mg/m 2 once weekly for four weeks. In this post hoc, non-randomized comparison, inve…
ADHD medications won't increase adults' heart risks, says study – CBS News
ThirdAgeADHD medications won't increase adults' heart risks, says studyCBS NewsThat sounded an alarm among researchers who thought those increases might lead to more heart attacks, strokes, or heart failure among pill-takers. "There had be…
Bone marrow and blood stem cell transplant survival rates equal, when donor is … – PhysOrg.com
Bone marrow and blood stem cell transplant survival rates equal, when donor is …PhysOrg.comPatients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft…